BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36156759)

  • 1. Vitamin D
    Patel P; Shah J
    Metab Brain Dis; 2022 Dec; 37(8):2653-2667. PubMed ID: 36156759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin ameliorates cognitive deficit, expression of amyloid precursor gene, and pro-inflammatory cytokines in an experimental models of Alzheimer's disease in Wistar rats.
    Safarzadeh E; Ataei S; Akbari M; Abolhasani R; Baziar M; Asghariazar V; Dadkhah M
    Exp Gerontol; 2024 Aug; 193():112466. PubMed ID: 38821324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D
    Yamini P; Ray RS; Chopra K
    Inflammopharmacology; 2018 Feb; 26(1):39-55. PubMed ID: 28702935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.
    Suganthy N; Malar DS; Devi KP
    Metab Brain Dis; 2016 Aug; 31(4):937-49. PubMed ID: 27188290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic vitamin D
    Lin J; Niu Z; Xue Y; Gao J; Zhang M; Li M; Peng Y; Zhang S; Li W; Zhang Q; Li X
    Neurosci Lett; 2022 Jul; 783():136725. PubMed ID: 35697158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nobiletin prevents amyloid β
    Ghasemi-Tarie R; Kiasalari Z; Fakour M; Khorasani M; Keshtkar S; Baluchnejadmojarad T; Roghani M
    Metab Brain Dis; 2022 Jun; 37(5):1337-1349. PubMed ID: 35294678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Walnuts on Cognition and Brain Health.
    Chauhan A; Chauhan V
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Increases Aβ140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients.
    SanMartin CD; Henriquez M; Chacon C; Ponce DP; Salech F; Rogers NK; Behrens MI
    Curr Alzheimer Res; 2018; 15(6):561-569. PubMed ID: 29283046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Aβ oligomers to rats.
    Baerends E; Soud K; Folke J; Pedersen AK; Henmar S; Konrad L; Lycas MD; Mori Y; Pakkenberg B; Woldbye DPD; Dmytriyeva O; Pankratova S
    Acta Neuropathol Commun; 2022 Aug; 10(1):113. PubMed ID: 35974377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ang(1-7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents.
    Varshney V; Garabadu D
    Mol Biol Rep; 2021 May; 48(5):4319-4331. PubMed ID: 34075536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astaxanthin ameliorates scopolamine-induced spatial memory deficit via reduced cortical-striato-hippocampal oxidative stress.
    Al-Amin MM; Mahmud W; Pervin MS; Ridwanul Islam SM; Ashikur Rahman M; Zinchenko A
    Brain Res; 2019 May; 1710():74-81. PubMed ID: 30552898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
    Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
    J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.